Sarepta Therapeutics Total Non-Operating Income/Expense 2010-2025 | SRPT
Sarepta Therapeutics total non-operating income/expense for the twelve months ending March 31, 2025 was $-0.047B, a 136.45% decline year-over-year.
- Sarepta Therapeutics annual total non-operating income/expense for 2024 was $0.043B, a 116.92% decline from 2023.
- Sarepta Therapeutics annual total non-operating income/expense for 2023 was $-0.252B, a 64.07% increase from 2022.
- Sarepta Therapeutics annual total non-operating income/expense for 2022 was $-0.154B, a 477.22% decline from 2021.